Petroleum Geo-Services ASA: Second Quarter Presentation

OSLO, NORWAY, Jul 29 (MARKET WIRE) —

The second quarter presentation can be downloaded at www.newsweb.no or
www.pgs.com

FOR DETAILS, CONTACT:

Tore Langballe, SVP Corporate
Communications
Phone: +47 67 51 43 75
Mobile: +47 90 77 78 41

Bard Stenberg, Investor Relations Manager
Phone: +47 67 51 43 16

Mobile: +47 99 24 52 35

US Investor Services
Phone: +1 281 509 8712

This information is
subject of the disclosure requirements acc. to Section 5- 12 vphl
(Norwegian Securities Trading Act)

[HUG#1434696]

Q2 2010
Presentation: http://hugin.info/115/R/1434696/380258.pdf

This
announcement is distributed by Thomson Reuters on behalf of

Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and

other applicable laws; and

(ii) they are solely responsible for the content, accuracy and

originality of the information contained therein.

Source: Petroleum
Geo-Services ASA via Thomson Reuters ONE

Copyright 2010, Market Wire, All rights reserved.

Petroleum Geo-Services ASA: Second Quarter and First Half 2010 Results

July 29, 2010: OSLO, NORWAY – Petroleum Geo-Services ASA (“PGS” or the “Company”)
reported an EBITDA of $71.4 million (33 percent margin) in Q2 2010. The results were
impacted by significant investments in vessel upgrades and repositioning of vessels, as
earlier indicated. The upgrades further strengthen PGS’ fleet as the most cost effective
in the industry.

§ Group performance: Q2 2010 revenues were $214.9 million, with a corresponding EBIT of
$5.3 million, compared to revenues of $294.3 million in Q2 2009 and an EBIT of $32.9
million.

§ Marine: Q2 2010 revenues were lower compared to the same period last year, primarily
driven by more time spent steaming and at yard, lower prices for Marine contract work
with 2009 having benefited from activity priced before the credit crunch, and lower
MultiClient pre-funding revenues. Industry capacity additions scheduled for 2010
continue to put pressure on conventional streamer pricing.

§ Most of the 2010 GeoStreamer capacity sold: Strong customer interest for GeoStreamer
continues. Ramform Valiant was equipped with GeoStreamer in June and Ramform Explorer
completed the same upgrade in July.

§ GeoStreamer price uplifts: Relative pricing differentiation for GeoStreamer work
continues to improve with margins of more than 1000 basis points above conventional
streamer margins.

§ Order book increasing: Order book increased by approximately $90 million from Q1 2010
and total order book is now $499 million.

§ Two break-through contracts for OptoSeis: PGS has signed an agreement with Petrobras
to install a fiber-optic system at the Jubarte field, and a collaboration agreement with
Shell to develop an onshore fiber-optic exploration and reservoir monitoring system.

§ More flexible credit facility: The Company amended its revolving credit and Term Loan
B facility in May 2010 to increase financial flexibility.

§ Negative net financial items: Foreign exchange fluctuations and amendment and
redemption of credit facilities resulted in a cost of $18.2 million in Q2 2010.

§ Organizational changes implemented: Following sale of the Onshore business PGS
implemented its new organizational structure.

§ EBITDA guidance maintained: The Company maintains its full year EBITDA guidance of
$450 million, supported by GeoStreamer success and increased MultiClient pre-funding
revenues in the second half, offset by a weak contract market for conventional streamers
and some MultiClient late sales uncertainty.

Jon Erik Reinhardsen, Chief Executive Officer and President of PGS, commented:

“The upgrade of Ramform Explorer to become one of the most efficient vessels in the
industry will together with the GeoStreamer upgrade of Ramform Valiant and delivery of
the new PGS Apollo pave the way for increased efficiency and reduced exposure to the
industry cycles. The second quarter was impacted by repositioning of vessels and
significant investments in vessel and GeoStreamer upgrades. New industry capacity will
continue to put pressure on pricing in the second half, but we remain on track to meet
our current full year EBITDA guidance.”

Key Financial Figures Quarter ended Six months ended June 30, Year ended December 31, 2009
(In millions of dollars, except per share data) June 30, Audited 1)
2010 2009 2010 2009
Unaudited Unaudited Unaudited Unaudited
Revenues from continuing operations $ 214.9 $ 294.3 $ 474.3 $ 685.1 $ 1,350.2
Adjusted EBITDA (as defined) 71.4 154.1 170.7 360.5 672.1
EBIT excluding special items 2) 5.3 81.2 40.1 236.3 386.9
EBIT 5.3 32.9 39.6 137.5 233.3
Income (loss) before income tax expense (27.4) 40.2 (12.4) 129.8 228.1
Net income (loss) to equity holders (22.3) 41.0 (6.1) 95.2 165.8
Basic earnings per share ($ per share) (0.11) 0.22 (0.03) 0.53 0.88
Diluted earnings per share ($ per share) (0.11) 0.22 (0.03) 0.53 0.88
Net cash provided by operating activities 63.8 208.1 179.3 353.5 676.1
Cash investment in MultiClient library 51.7 56.7 103.8 101.6 183.1
Capital expenditures 52.7 56.8 100.6 150.5 231.2
Total assets (period end) 2,690.4 3,132.4 2,690.4 3,132.4 2,929.4
Cash and cash equivalents (period end) 159.8 168.1 159.8 168.1 126.0
Net interest bearing debt (period end) $ 616.3 $ 962.1 $ 616.3 $ 962.1 $ 774.0

1) Financial information for the full year 2009 is derived from the audited financial
statements as presented in the 2009 Annual Report.
2) Impairment charges of $0.5 million in Q1 2010 and $153.6 million for the full year
2009.

Complete Q2 2010 earnings release can be downloaded at www.newsweb.no
http://www.newsweb.no/ or www.pgs.com http://www.pgs.com/

FOR DETAILS, CONTACT:
Tore Langballe, SVP Corporate Communications

Phone: +47 67 51 43 75

Mobile: +47 90 77 78 41

Bård Stenberg, Investor Relations Manager

Phone: +47 67 51 43 16

Mobile: +47 99 24 52 35

US Investor Services

Phone: +1 281 509 8712

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

TGS: TGS Q2-2010 Webcast and Teleconference

ASKER, NORWAY (29 July 2010) – TGS will publish its Q2-2010 results at approximately
08:00 CET on 5 August 2010.

Robert Hobbs (CEO) and Kristian Johansen (CFO) will present the results at 08:30 CET the
same morning at Shippingklubben located at Haakon VII’s gt 1 in Oslo, Norway. The
presentation is open to the public. The presentation can be followed live on the
internet at www.tgsnopec.com http://www.tgsnopec.com/ streamed by Webcast Norge.

The slides from the presentation will also be available in PDF format at both the TGS
and Oslo Stock Exchange websites and a recorded version of the presentation will be
available shortly thereafter at www.tgsnopec.com.

CEO Robert Hobbs and CFO Kristian Johansen will also host a conference call on 5 August
2010 at 14:00 CET (8:00 AM New York time). Norwegian attendees are invited to call +47
2316 2190 or 800 19640, International attendees are invited to call 44 (0)20 7806 1951
or 0800 028 1243 and USA attendees are invited to call +1 718 354 1387 or 866 935 4575.
Attendees may want to call 5-10 minutes before 14:00 CET (8:00 AM NY) to ensure
registration and access.

Participants will need to quote the following confirmation code when dialing into the
conference: 4690410.

A Q&A session will follow a short introduction, based upon the presentation issued in
the morning. To pose a question, please press *1.

A replay of the conference call will be available shortly after. To access replay of TGS
conference call,

* dial +47 2100 0498 (Norway), +44 (0)20 7111 1244 (International) or +1 347 366 9565
(USA)
* replay access code 4690410 followed by # (pound-sign)

A replay of the conference call will also be available at www.tgsnopec.com
http://www.tgsnopec.com/ .

Company summary

TGS-NOPEC Geophysical Company (TGS) provides global geoscience data products and
services to the oil and gas industry for the exploration and delineation of hydrocarbon
reserves. We design and acquire multi-client data projects worldwide that make up our
data library of seismic, gravity/magnetic and well data, enhanced by our seismic imaging
technology and regional interpretation expertise. Visit TGS online at www.tgsnopec.com
http://www.tgsnopec.com/ .

Forward-looking statements and contact information

All statements in this press release other than statements of historical fact are
forward-looking statements, which are subject to a number of risks, uncertainties and
assumptions that are difficult to predict, and are based upon assumptions as to future
events that may not prove accurate. These factors include TGS’ reliance on a cyclical
industry and principal customers, TGS’ ability to continue to expand markets for
licensing of data, and TGS’ ability to acquire and process data products at costs
commensurate with profitability. Actual results may differ materially from those
expected or projected in the forward-looking statements. TGS undertakes no
responsibility or obligation to update or alter forward-looking statements for any
reason.

TGS-NOPEC Geophysical Company ASA is listed on the Oslo Stock Exchange (OSLO:TGS).

For additional information about this news release please contact:

Kristian Johansen
Chief Financial Officer
Office: +47 667 69931
Cell: +47 47 60 33 34
Email: kristian.johansen@tgsnopec.com mailto:kristian.johansen@tgsnopec.com

Karen El-Tawil
VP, Business Development
Office: +1 713 860 2102
Cell: +1 713 806 2420
Email: karen.el-tawil@tgsnopec.com mailto:karen.el-tawil@tgsnopec.com

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

Renewable Energy Corporation ASA: Second quarter 2010 – presentation material

Enclosed is REC’s interim results presentation for the second quarter 2010. The
presentation will be held at 08:00 CET today at the conference center Høyres Hus (Oslo,
Norway).

More details on today’s program and the presentation will available on REC’s internet
pages: www.recgroup.com http://www.recgroup.com

About REC
REC is a leading vertically integrated player in the solar energy industry. REC is among
the world’s largest producers of polysilicon and wafers for solar applications, and a
rapidly growing manufacturer of solar cells and modules. REC is also engaged in project
development activities in selected PV segments. Founded in Norway, REC is an
international solar company, employing close to 4,000 people worldwide. REC had revenues
in excess of NOK 9 billion in 2009. Please visit www.recgroup.com
http://www.recgroup.com to learn more about REC.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

KAEL-GemVax reports significant interim progress in UK TeloVac Phase III study of GV1001 anti-telomerase vaccine in pancreatic cancer

* Recruitment 70% complete for only vaccine in Phase III targeting pancreatic
cancer
* Breakthrough potential as “universal” therapeutic cancer vaccine

OSLO, Norway–(Business Wire)–
KAEL-GemVax, a leading oncology vaccine company, today announced, through its
subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III
TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in
pancreatic cancer. The company also strongly believes GV1001 has major
“blockbuster” potential as a universal therapeutic cancer vaccine and is
developing a strong pipeline for other indications, including lung and liver
cancer and melanoma.

The largest cancer vaccine therapy trial ever in the UK, currently funded by
Cancer Research UK, the TeloVac study is being run by the Liverpool Cancer
Trials Unit. KAEL-GemVax has just received the second interim report noting that
the number of patients recruited reached 755 out of 1110 in 52 centres in the UK
in June. This means recruitment is now almost 70% complete and remains well on
schedule for LPFV in October 2011 and NDA filing soon after. A recent
Datamonitor report forecasted the market for therapeutic cancer vaccines to
reach $4.7 billion by 2018 in 7 major markets.

Director of the LCTU, Professor John Neoptolemos commented: “GV1001 is the most
advanced therapeutic cancer vaccine currently in development and we are
extremely pleased with the progress of trials so far. Patient recruitment across
our centres continues and we are seeing some good immunological responses.”

The primary trial objective is length of survival. The TeloVac study was
initiated in 2007 after the Phase I/II study showed overall survival of 8.6
months, compared to the 5.6 months of current standard treatment Gemcitabine. It
is a prospective, controlled, multicentre, randomised clinical trial comparing
combination Gemcitabine and Capecitabine therapy with concurrent and sequential
chemoimmunotherapy using a telomerase vaccine in locally advanced and metastatic
pancreatic cancer.

KAEL-GemVax CEO Dr Jay Sangjae Kim added: “These results from the independent
Data Monitoring Committee on the TeloVac trial in the UK are extremely
encouraging. Currently pancreatic cancer is one of the most difficult cancers to
treat and there are only a few approved treatments on the market. However, we
believe that the improved overall survival and favourable safety profile that
GVI001 has shown in previous studies creates a strong rationale for providing it
with standard care, and thus creating the first therapeutic vaccine for patients
with pancreatic cancer. In addition, we strongly believe that GV1001 has the
potential to overcome the limits of other current cancer vaccines and become
part of the standard of care not only for pancreatic cancer but for various
other types of cancers. In other words a truly “universal” vaccine will be
available in the near future.”

Corporate Inquiries
KAEL-GemVax
Yena Chung, Global PR Manager
Tel: +82-2 540 6221
Email: yenachung@kaelgemvax.com
or
Media Inquiries
Schwartz Communications
Richard Hayhurst
Tel: +44 (0)7950 878 218
Email: Rhayhurst@schwatrtzcomm.com
or
Schwartz Communications US
Ben Navon
Tel: +1 781-684-0770
Email: Bnavon@schwartzcomm.com

Copyright Business Wire 2010

GTB Invest ASA: CFO leaves GTB

CFO Jon A. Elde is leaving GTB Invest ASA. Deputy CEO Garup Meidell will take over the
roles of CFO. The transition will at the latest take place 31. October 2010.

GTB Invest ASA – Sjølyst plass 2, NO-0278 Oslo – Norway
Office: +47 23 01 49 73 – Fax: +47 23 01 49
www.gtbinvest.no http://www.ggs-spectrum.com/

Statoil Awards Accenture Five-Year Finance & Accounting Business Process Outsourcing Contract

OSLO, Norway–(Business Wire)–
Accenture (NYSE: ACN) has signed a five-year business process outsourcing (BPO)
contract with Statoil, an international energy company with operations in 40
countries, to manage the company`s Accounts Payables processes. Financial
details of the contract were not disclosed.

The agreement is designed to improve the efficiency and effectiveness of
Statoil`s Accounts Payable function by reengineering processes and increasing
automation supported through Accenture`s Global Delivery Network using centers
in Norway, the Czech Republic and India. The delivery of the outsourced services
is scheduled to begin in September 2010.

“We are excited and honored to have been awarded this contract by Statoil and
are looking forward to continuing our long term collaboration in a new area,”
said Kristian Kvam, executive director of Accenture`s Nordic Energy Industry
Group. “This is an excellent opportunity for Statoil to leverage our
market-leading BPO capability in the next step of its shared services journey.”

Accenture has worked with Statoil since the late 1970`s, in the areas of
Management Consulting and Technology Services.

Learn more about Accenture`s outsourcing services.

About Accenture

Accenture is a global management consulting, technology services and outsourcing
company, with more than 190,000 people serving clients in more than 120
countries. Combining unparalleled experience, comprehensive capabilities across
all industries and business functions, and extensive research on the world`s
most successful companies, Accenture collaborates with clients to help them
become high-performance businesses and governments. The company generated net
revenues of US$21.58 billion for the fiscal year ended Aug. 31, 2009. Its home
page is www.accenture.com.

Accenture
Matthew McGuinness
+44 20 7844 9683
+44 77 400 38921
matthew.mcguinness@accenture.com
or
Christine Fields
+1 216 535 5092
christine.fields@accenture.com

Copyright Business Wire 2010

Petroleum Geo-Services ASA: Repurchase of shares

June 28, 2010, Oslo, Norway – Petroleum Geo-Services ASA (“PGS”or the “Company”)
(OSE and NYSE: PGS) announces that PGS purchased today 300.000 own shares on the Oslo
Børs
at an average price of NOK 61,56 per share. The shares are purchased to be used in PGS’
employee
option program.
Following the transaction PGS holds a total of 900.000 own shares, representing 0,45% of
total
shares outstanding.

Contact:
Tore D Langballe
Phone: +47 90 77 78 41

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

Clavis Pharma ASA: Clavis Pharma announces the appointment of Athos Gianella-Borradori, MD

Oslo, Norway, June 24, 2010

Clavis Pharma ASA (OSE: CLAVIS) announces the appointment of Athos Gianella-Borradori MD
as Chief Medical Officer (CMO). Dr Gianella-Borradori is an experienced
onco-hematologist and drug developer, with 30 years experience in the field. He spent
the past 20 years in industry, focused on translational research and on the clinical
development of novel anti-cancer agents. During this career, he has held managerial and
senior clinical research and development roles at Novartis (Switzerland), Crucell (The
Netherlands), Bavarian Nordic (Germany), Cyclacel (United Kingdom) and, for the last
five years, at Serono, later at Merck Serono (Switzerland).

Before joining the industry, Dr Gianella-Borradori received his medical degree from the
University of Bern (Switzerland). He is board certified in Pediatric Hematology and
Oncology and practised for several years at European and US universities.

Dr Gianella-Borradori’s primary role at Clavis will be to drive the clinical development
of, elacytarabine, which is in a Phase III trial for patients with acute myeloid
leukaemia (AML), and of CP-4126 in partnership with Clovis Oncology, which is in Phase
II for patients with pancreatic cancer. He will also contribute to shape the strategy of
Clavis and will play a major role in the future developments of Clavis’ novel cancer
drug candidates.

Olav Hellebø, CEO, said: “We are very pleased that Athos will be joining the Clavis team
as CMO. We believe his extensive international experience in cancer drug development and
clinical experience in oncology and haematology will prove extremely valuable as we
progress our existing clinical programmes and expand our exciting pipeline of novel
LVT-derived cancer candidates. We believe the improved clinical characteristics of these
new drug candidates offer the potential to make a significant difference to the
treatment of patients with a range a cancer types.”

For further information contact:
Olav Hellebø
Chief Executive Officer
+47 24 11 09 50
olav.hellebo@clavispharma.com mailto:olav.hellebo@clavispharma.com

Gunnar Manum
Chief Financial Officer
+47 24 11 09 71
+47 95 17 91 90 (mob)
gunnar.manum@clavispharma.com mailto:gunnar.manum@clavispharma.com

Mark Swallow / Nina Enegren / David Dible
Citigate Dewe Rogerson
+44 207 282 2948
clavispharma@citigatedr.co.uk mailto:mark.swallow@citigatedr.co.uk

About Clavis Pharma
Clavis Pharma ASA is a clinical stage oncology drug development company based in Oslo,
Norway with a portfolio of novel anti-cancer drugs in development. These patented New
Chemical Entities (NCEs) are novel, improved versions of commercially successful drugs,
made using Clavis Pharma’s Lipid Vector Technology (LVT) chemistry. Data generated
suggests these potential breakthrough products may offer improved efficacy and reduced
side effects through enhanced pharmacokinetic properties, greater tissue penetration,
altered metabolism and, in certain cases, additional modes of action.

Clavis Pharma’s has several drug candidates in formal development studies:

*

Elacytarabine, an improved form of Ara-C, a leukaemia drug – about to commence a Phase
III randomized, controlled registration study in late-stage acute myeloid leukaemia;

*

Intravenous CP-4126, an improved version of gemcitabine – currently in a Phase II
comparative study with gemcitabine for the treatment of pancreatic cancer;

*

CP-4200, an azacitidine derivative – in preclinical development for myelodysplastic
syndrome (MDS), often a precursor to myeloma or leukaemia.

Clavis Pharma intends to commercialise its products through strategic alliances and
partnerships with experienced oncology businesses and, where and when commercially
appropriate, by establishing its own sales and marketing capabilities. CP-4126 is
licensed to Clovis Oncology in the Americas and Europe. Clavis Pharma has retained
rights in other territories and an option to co-promote CP-4126 in Europe.

The shares of Clavis Pharma ASA are listed on the Oslo Stock Exchange (ticker: CLAVIS).

Disclaimer
This news release contains forward-looking statements and forecasts based on
uncertainty, since they relate to events and depend on circumstances that will occur in
the future and which, by their nature, will have an impact on results of operations and
the financial condition of Clavis Pharma. There are a number of factors that could cause
actual results and developments to differ materially from those expressed or implied by
these forward-looking statements. Theses factors include, among other things, risks
associated with technological development, the risk that research & development will not
yield new products that achieve commercial success, the impact of competition, the
ability to close viable and profitable business deals, the risk of non-approval of
patents not yet granted and difficulties of obtaining relevant governmental approvals
for new products.

No expressed or implied representations or warranties are given concerning Clavis Pharma
or the accuracy or completeness of the information provided herein, and no claims shall
be made by the recipient hereof by virtue of this News Announcement or the information
contained herein.

Clavis Pharma(TM) is a registered trademark of Clavis Pharma ASA.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

Petroleum Geo-Services ASA: PGS – Repurchase of shares

June 23, 2010, Oslo, Norway – Petroleum Geo-Services ASA (“PGS”or the “Company”)
(OSE and NYSE: PGS) announces that PGS purchased today 300.000 own shares on the Oslo
Børs
at an average price of NOK 68,03 per share. The shares are purchased to be used in PGS’
employee
option program.
Following the transaction PGS holds a total of 600.000 own shares, representing 0,30% of
total
shares outstanding.

Contact:
Tore Langballe
Phone: +47 67 51 43 75
Cellular: +47 90 77 78 41

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

Technip Awarded Term Agreement with BG in the North Sea

PARIS–(Business Wire)–
Regulatory News:

Technip (Paris:TEC) (ISIN:FR0000131708) has been awarded a major four-year term
agreement by BG Group for the provision of pre-FEED(1), FEED, full EPIC(2) and
IRM(3) services in both the United Kingdom and Norwegian Continental Shelves.
The agreement contains a provision to extend the contract with a further three
one-year options.

This agreement, which takes immediate effect, will apply to multiple field
developments and is already being applied to the Blake, Flank and Pi projects
using vessels from Technip`s suite of pipelay, construction, trenching, survey &
utility and DSV(4) assets.

Knut Boe, Senior Vice President of Technip`s North Sea Canada Region, commented:
“We are delighted that BG Group has recognized Technip`s ability to deliver a
full package of services.”

“This agreement builds on our existing long-standing relationship with BG and
reinforces Technip`s leading position in the North Sea Subsea sector. We will
support BG throughout this agreement from our operating centers in Aberdeen,
Scotland and Oslo, Norway.”

Genesis, DUCO and Flexi France, all of which are Technip Group entities, will
also play a part in executing the contract.

(1) FEED – front-end engineering and design

(2) EPIC – engineering, procurement, installation and commissioning

(3) IRM – inspection, repair and maintenance

(4) DSV – Diving Support Vessel

°

° °

Technip is a world leader in the fields of project management, engineering and
construction for the oil & gas industry, offering a comprehensive portfolio of
innovative solutions and technologies.

With 23,000 employees around the world, integrated capabilities and proven
expertise in underwater infrastructures (Subsea), offshore facilities (Offshore)
and large processing units and plants on land (Onshore), Technip is a key
contributor to the development of sustainable solutions for the energy
challenges of the 21st century.

Present in 48 countries, Technip has operating centers and industrial assets
(manufacturing plants, spoolbases, construction yard) on five continents, and
operates its own fleet of specialized vessels for pipeline installation and
subsea construction.

The Technip share is listed on NYSE Euronext Paris exchange and over the counter
(OTC) in the USA.

Technip
Public Relations
Christophe Bélorgeot
Tel. +33 (0) 1 47 78 39 92
or
Floriane Lassalle-Massip
Tel. +33 (0) 1 47 78 32 79
E-mail: press@technip.com
or
Investor and Analyst Relations
Kimberly Stewart
Tel. +33 (0) 1 47 78 66 74
E-mail : kstewart@technip.com
or
Group websitehttp://www.technip.com

Copyright Business Wire 2010

NorDiag ASA: NORD – Commencement of last possible exercise period for Class B Warrants

According to a resolution by the extraordinary general meeting on 18 December 2009,
today is the first day of the last possible exercise period for Class B Warrants in
Nordiag ASA. Class B Warrants may be exercised in the period 15-30 June 2010

According to the amended exercise terms, which were resolved by the extraordinary
general meeting on 18 December 2009, each Class B Warrant gives the right to require
issued 3.38323 new shares in NorDiag ASA, each with a nominal value of NOK 1, at a
subscription price of NOK 2.18 per share, provided that fractional shares will not be
issued.

According to the resolution by the general meeting, B-Warrants shall be exercised by way
of written notification to the NorDiag’s Board of Directors, clearly instructing the
company that the subscription right shall be exercised, and including the number of
shares to be subscribed.

The company requests that such instructions are sent by e-mail to: investor@nordiag.com
mailto:investor@nordiag.com or to fax no. +47 22 02 65 66.

Contact:

CFO Tone Kvåle Phone + 47 915 19576

About NorDiag:

NorDiag is a biotechnology company developing, manufacturing and marketing automated
solutions (instruments and reagents) for sample preparation of DNA from difficult
biological samples for large and small laboratories. NorDiag was founded in 2003 and has
its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm,
Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 35.3
man-labor years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.

For further information – www.nordiag.com http://www.nordiag.com/ .

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

Vizrt Ltd.: Portugal’s Impresa Group chooses Vizrt’s Online Suite

Oslo, Norway, June 14, 2010 Vizrt Ltd. (Oslo Main List: VIZ)

Vizrt, a leading provider of content production tools for the digital media industry,
announced today that the company has been chosen by IMPRESA Group, Portugal’s largest
media group, to supply an Online Suite for its Multimedia Strategy.

Impresa has chosen a number of Vizrt applications that cover all aspects of today’s
content management workflow, including several Escenic, MAM and Adactus products.

Francisco Maria Balsemão, Vice President and CTO at Impresa, stated, “We decided to
invest in our ability to manage and deliver content on a variety of platforms in order
to improve our presence and to enable us to access multiple revenue streams. At the same
time, we needed to make our workflow as efficient as possible, which led to our choosing
Vizrt due to the high level of integration and efficiencies that in our view no other
company on the market can deliver to this extent. The fact that Vizrt Web Content
Management solution is specifically tailored for our industry has had a major impact in
our decision.”

Martin Burkhalter, CEO for Vizrt, stated, “We are very proud to have won the Impresa
deal, especially as it is witness to Vizrt’s vision and strategy to support clients in
an integrated way in their production, management, delivery and distribution of digital
media content. This contract includes a variety of Vizrt’s offerings from our product
lines such as Online, Media Asset Management and Mobile Streaming (Adactus), In our
opinion, this deal is a great showcase of where we see the industry headed.”

Alexandra Solheim, Sales Manager Online Products, Vizrt, explained, “Impresa has chosen
a unique state of the art converged Multimedia Newsroom. Where competitors simply
combine print and web, Impresa uses Vizrt’s Online Suite to merge newsrooms operations
for print, web, mobile and broadcast. Now content can be cross published through Escenic
Content Studio with simple drag and drop operations”.

Products included in the deal are the Escenic Content Engine for content management,
Escenic Mobile Solution for cross platform publication, Escenic Community Engine which
allows for easy community building, Adactus Mobilize Transcoding platform for ingest,
transcoding and publishing, Viz Video Hub as a media asset management system, as well as
the Escenic Widget Template Framework to efficiently implement websites.

About Impresa:

Impresa Group is Portugal’s largest media group and has a turnover of 253.3 million
Euros in 2009. The activity is divided into three business areas; SIC, IMPRESA
Publishing and IMPRESA Digital, with interests which cover a FTA television, cable
channels, the newspaper Expresso, an extensive portfolio of magazines, various Internet
properties as well as interests in the distribution and events production.

About Vizrt:

Vizrt provides real-time 3D graphics and asset management tools for the broadcast
industry – from award-winning animations & maps to online publishing tools.

Vizrt’s products are used by the world’s leading broadcasters and publishing houses,
including: CNN, CBS, Fox, the BBC, BSkyB, ITN, Tele5, laSexta, ETB, TV3, Antena3 and FC
Barcelona, The Globe and Mail, Times Online, The Telegraph, and Welt Online.
Furthermore, many world-class production houses and corporate institutions such as the
Stock Exchanges in New York and London use Vizrt systems.

Vizrt is a public company traded on the Oslo Main List: VIZ, ISIN: IL0010838154.

Investors and media contacts:

Martin Burkhalter
CEO
+41 (79) 795 24 48
mbu@vizrt.com

Ofra Brown
CFO
+47 5351 8040
ofra@vizrt.com

SCHWARZ Financial Communication
Frank Schwarz
+49 611 1745 398 11
schwarz@schwarzfinancial.com

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian
Securities Trading Act)

HUG#1423488

Press Release as PDF http://hugin.info/138784/R/1423488/372350.pdf

Aker Solutions ASA: Aker Solutions completes Gjøa platform for the North Sea

13 June 2010 – The semi-submersible platform by Aker Solutions for the Gjøa oil and gas
field offshore Norway, today started on its journey from the yard at Stord to the North
Sea, where installation will take place. Production start-up is scheduled for the fourth
quarter of 2010.

Gjøa features innovative solutions by Aker Solutions, based on the company’s experience
from more than 50 semi-submersibles. It will be Statoil’s first floating platform
supplied with power from shore. This is expected to reduce carbon emissions by approx
250,000 tonnes per year.

Gjøa is one of the largest ongoing field development projects in the North Sea. Aker
Solutions has designed, engineered and assembled the platform, which will connect to
five subsea templates. With a topside weight of 22.000 tonnes and hull dry weight of
15.000 tonnes, the new platform is ready to create value for its operators and Norwegian
society in decades to come.

“We are proud to deliver the Gjøa platform to Statoil ready for operation in the
northern part of the North Sea. Gjøa is a strategically important project for Aker
Solutions, underpinning our position as a leading supplier of floating platforms for oil
and gas production. Today’s sail away confirms our competence and track record within
this area,” says Jarle Tautra, executive vice president in Aker Solutions.

The Gjøa deck measures 110 meters long and 85 meters wide, an area larger than a
football (soccer) field. The platform’s highest point is the flare tower at 143 meters,
several floors higher than Norway’s tallest building, Oslo Plaza, at 117 meters. In
total, more than 500 Aker Solutions engineers have been mobilised to design the
platform, from Oslo, Norway, and Mumbai, India. During the final assembly at Stord, peak
manning reached 3000 skilled operators. Key deliveries have also been made by other Aker
Solutions locations in Norway, including Egersund, Verdal, Moss and Pusnes.

Installation of the mooring system, transportation and installation of the Gjøa platform
is carried out by Aker Solutions’ subsidiary Aker Marine Contractors.

“The delivery of Gjøa continues our good working relationship with Statoil from the
similar, but slightly smaller Kristin platform which we completed a few years ago. We
are proud to be their partner in further developing oil and gas resources in the North
Sea and beyond. We thank them for their confidence. I would also personally like to
congratulate the thousands of employees and subcontractors involved in this project, on
a job well done!” says Tautra.

Licencees to the Gjøa field are Statoil, development operator (20%), GDF SUEZ E&P Norge
AS, production operator (30%), Petoro (30%), Shell (12%) and RWE Dea (8%). Estimated
recoverable reserves amount to 82 million barrels of oil and condensate, and 40 billion
cubic metres of gas. In addition, the Vega satellite field has estimated reserves of 26
million barrels of condensate and 18 billion cubic metres of gas. The gas will be sent
through the Flags pipeline to Scotland while the oil will be piped to Statoil’s refinery
at Mongstad.

(Attached photos: Statoil.)

ENDS

For further information, please contact:

Media:
Alf Terje Myklebust, communication manager, Aker Solutions, Stord. Tel: +47 53 41 81 03,
Mob: +47 91 75 34 42

Investor relations:
Lasse Torkildsen, SVP Investor Relations, Aker Solutions. Tel: +47 67 51 30 39, Mob: +47
911 37 194

Suppliers:
For further information about sourcing and potential subcontracts for this project,
please contact the relevant BA Global Sourcing Champion

http://www.akersolutions.com/Internet/SuppliersCentre/Contacts/SupplyManagementContacts.htm

.

Career opportunities:
Visit http://www.akersolutions.com/careers http://www.akersolutions.com/careers

Aker Solutions ASA, through its subsidiaries and affiliates (“Aker Solutions”), is a
leading global provider of engineering and construction services, technology products
and integrated solutions. Aker Solutions’ business serves several industries, including
oil & gas, refining & chemicals, mining & metals and power generation. The Aker
Solutions group is organised in a number of separate legal entities. Aker Solutions is
used as the common brand/trademark for most of these entities.

Aker Solutions’ parent company is Aker Solutions ASA. Aker Solutions has aggregated
annual revenues of approximately NOK 54 billion and employs approximately 22 000 people
in about 30 countries.

Aker Solutions is part of Aker (www.akerasa.com http://www.akerasa.com/ ), a group of
premier companies with a focus on energy, maritime and marine resource industries. The
Aker companies share a common set of values and a long tradition of industrial
innovation. As an industrial owner controlling 40.27 percent of the shares in Aker
Solutions through Aker Holding AS, Aker ASA takes an active role in the development of
Aker Solutions.

This press release may include forward-looking information or statements and is subject
to our disclaimer, see www.akersolutions.com http://www.akersolutions.com/ .

HUG#1423496

gjoa-statoil3 http://hugin.info/77/R/1423496/372363.jpg gjoa-statoil1
http://hugin.info/77/R/1423496/372361.jpg factsheet-english
http://hugin.info/77/R/1423496/372360.pdf gjoa-statoil2

http://hugin.info/77/R/1423496/372362.jpg

Media Advisory: Indian and Northern Affairs Canada

OSLO, NORWAY, Jun 04 (MARKET WIRE) —
Please be advised that the Honourable Chuck Strahl, Minister of Indian
Affairs and Northern Development and Federal Interlocutor for Metis and
Non-Status Indians will be speaking at the International Polar Year (IPY)
conference in Oslo, Norway.

The IPY conference “Polar Science – Global Impact” is
considered the largest polar science gathering ever held, and features
the latest results of IPY research and polar science from around the
world.

When: Wednesday, June 9
8: 45 a.m. (CET – Local time)
2: 45 a.m. (ET)
(i)Webcast may be viewed at the
following URL: www.ipy-osc.no

Where: Lilestrom Conference Centre
Oslo, Norway

Contacts:
To schedule an interview, with the Minister
or for more information, please contact:
Office of the Honourable Chuck Strahl
819-997-0002

INAC Media Relations Line
819-953-1160

Copyright 2010, Market Wire, All rights reserved.

Kistefos Comments on Trico Marine Services, Inc. Annual Meeting

Trico`s Largest Stockholder Says its Intention to Vote Against Company`s
Incumbent Directors and Management Proposals Has Not Changed
OSLO, Norway–(Business Wire)–
Kistefos AS, the largest stockholder of Trico Marine Services, Inc. (Nasdaq:
TRMA), today stated that it has not changed its previously announced intention
to vote against the company’s director nominees and other proposals at Trico’s
2010 Annual Meeting, currently scheduled for June 10, 2010. Kistefos said that
while it is encouraged that Trico has removed Joseph Compofelice as the
company`s chairman and CEO, a move that Kistefos had repeatedly urged the Board
take since October 2009, it still must hold the members of the Board standing
for reelection accountable for the loss of over 95% of the company’s market
value, as well as the Board’s failure to demonstrate how it will restore
stockholder value or describe a coherent strategy for resolving the company`s
ongoing crisis.

Kistefos stated that its basis for voting against the Company’s nominees and
proposals is further supported by the recently announced conclusions of two of
the leading U.S. proxy voting advisory firms. The ISS Proxy Advisory Services
division of RiskMetrics Group has recommended a vote against all three
directors, citing the company’s anemic stock and financial performance. Proxy
Governance has issued a report with the same recommendation, citing Trico`s
“remarkably poor performance” over the last three years. Those two
recommendations followed the report issued earlier by Glass Lewis & Co., which
advised stockholders to withhold support from 2 of the 3 director nominees and
from certain of the company’s proposals.

THIS IS NOT, NOR SHALL IT BE DEEMED TO BE, A SOLICITATION OF PROXIES FOR THE
COMPANY`S UPCOMING ANNUAL MEETING.

Investors with questions about the process of voting their shares held in Trico
may contact Okapi Partners LLC, our information agent, at (212) 297-0720.

About Kistefos AS

Kistefos AS is a private investment firm focused on making investments in
medium-sized companies. Kistefos typically invests in turnaround opportunities
and businesses that experience industry consolidation. Kistefos has holdings in
dry cargo-shipping, offshore services and financial services, as well as
technology-founded investments and real estate development. Kistefos AS was
founded in 1979 and is based in Oslo, Norway.

MEDIA:
Abernathy MacGregor
Tom Johnson, 212-371-5999
or
INVESTOR:
Okapi Partners LLC
Bruce H. Goldfarb / Pat McHugh
212-297-0720

Copyright Business Wire 2010

Norsk Hydro: Board member purchases shares

OSLO, NORWAY, Jun 02 (MARKET WIRE) —

Member of the Board of Directors in Norsk Hydro ASA, Bente Rathe, has on
June 2, 2010 purchased 5,000 shares in Hydro at NOK 37.96 per share. New
holding is 5,000 shares.

Investor contact
Contact Stian Hasle
Cellular +47 97736022
E-mail Stian.Hasle@hydro.com

This information is subject of the disclosure requirements acc. to
Section 5- 12 vphl (Norwegian Securities Trading Act)

[HUG#1421018]

Copyright 2010, Market Wire, All rights reserved.

Edvantage Group: Edvantage group partners with KESDEE to provide a full suite of financial e-learning content

Oslo, Norway – 01 June, 2010 – Edvantage group, an e-learning company and Managed
Learning Service provider, has entered into a reseller agreement with KESDEE, the
world’s largest financial e-learning company, to provide specialised learning resources
and on-demand e-learning content for the financial services industry.

This new partnership will provide financial institutions with the ability to build
advanced managed learning programmes using one provider. Over 750 e-learning courses
from KESDEE are now available through Learning Gateway, Edvantage group’s SaaS-based
Learning Management System.

“We are pleased to be able to offer high-quality e-learning content from KESDEE,” says
Thomas Berglund, CEO Edvantage group. “By combining the content for finance
professionals with our Managed Learning Service offering, financial organisations will
find it easier to meet their compliance needs and provide employees with quality
learning resources for specific topics, levels and goals.”

Swarna Jessica Srinivas, President of KESDEE, comments, “Edvantage group has a strong
reputation for delivering learning solutions to the financial sector, and is already a
learning partner to leading finance organisations in Europe. This partnership
strengthens our distribution channels and provides a win-win situation for everyone.
Financial organisations looking to gain a competitive edge by providing employees with
the best learning available can leverage this offering to improve learning programmes.
The complete offering of industry expertise and seamless selection and delivery of
learning content is certainly an advantage.”

[ENDS]

About Edvantage group

Edvantage group is a Managed Learning Service company providing a single-source for
corporate e-learning solutions. The company combines industry expertise, learning
systems and software, content and customised services to help clients develop employee
skills and improve performance. Edvantage group serves local, multinational and global
organisations from offices throughout the Nordic countries, Benelux and the UK. For more
information please visit www.edvantagegroup.com http://www.edvantagegroup.com/ .

About KESDEE

KESDEE is the world’s largest financial e-learning company. KESDEE’s e-learning
catalogue consists of 750 accredited e-learning courses on various topics in Banking,
Finance, Accounting, Insurance, and Risk Management. In addition, KESDEE offers
web-based Tutorials for Certification Exams in Risk Management and Financial Analysis.
KESDEE’s e-learning solutions are relevant for the providers of financial services, as
well as for users, regulators, advisors and educators of financial analysis. KESDEE
clients include Federal Reserve Board, FDIC, Citi, Standard Chartered Bank, IBM, Infosys
and SunGard.

Contact

Edvantage group

Thomas Berglund – CEO

+ 47 92 82 45 82

Thomas.berglund@edvantagegroup.com mailto:Thomas.berglund@edvantagegroup.com

KESDEE Inc.

Swarna Jessica Srinivas – President

+1- 858 558 8118

+1- 858 558 8228

media@kesdee.com mailto:media@kesdee.com

Exercise beats shockwaves for chronic shoulder pain

London, Sept 16 (ANI): Supervised exercise helps ease chronic shoulder pain better than sound shockwave treatment, a new study suggests.

In the study, published in the online British Medical Journal, team of researchers based in Oslo, Norway compared the effectiveness of radial extracorporeal shockwave treatment (low to medium energy impulses delivered into the tissue) with supervised exercises in patients with shoulder pain.

The research involved 104 men and women aged between 18 and 70 years.

Participants were randomised to receive either radial extracorporeal shockwave treatment (one session weekly for four to six weeks) or supervised exercises (two 45 minute sessions weekly for up to 12 weeks).

Both groups were similar at the start of the study with regard to age, education, dominant arm affected and pain duration.

All patients were monitored at six, 12 and 18 weeks and were advised not to have any additional treatment except analgesics (including anti-inflammatory drugs) during the follow-up period. Pain and disability were measured using a recognised scoring index.

After 18 weeks, 32 of patients in the exercise group achieved a reduction in shoulder pain and disability scores compared with 18 in the shockwave treatment group.

More patients in the exercise group returned to work, while more patients in the shockwave treatment group had additional treatment after 12 weeks, suggesting that they were less satisfied.

The authors conclude: “Supervised exercises were more effective than radial extracorporeal shockwave treatment for short term improvement in patients with subacromial shoulder pain.” (ANI)

Proteans expands in Northern Europe

Bangalore, Sep 2 (ANI/Business Wire India): In the tough economic conditions during the past few months, most IT/software outsourcing companies have shown flat or negative growth in their revenues. Companies have been looking at opportunities in new geographies and industries to get growth.

Proteans Software Solutions, one of the leading software R andD partners for product companies globally, has made significant advancement in customer acquisition in Northern Europe. Proteans is chosen between more recognized companies because of its quality people and its deep understanding of the Nordic market. Proteans now has some excellent customers in Norway and Sweden, and is looking at a strong pipeline in the region. The company operates in the region through its offices in Oslo, Norway and Stockholm, Sweden.

Anders Olsson, Vice President (Nordic Operations), says, “Nordic market is relatively new to offshoring for product development, and with Proteans’ specialization in product engineering, we see tremendous opportunities in the region. The customers like the talent, culture and delivery capability of Proteans, and we are very excited about growth in the Scandinavian market. “

Currently, Proteans is 300 strong, and now has three development centers in Bangalore with sales offices in US, UK, India and Nordics.

Proteans – a subsidiary of Norway-based CAMO ASA – has built over 150 globally successful products working with over 75 software product companies in the past six years. Currently the company is engaged with around 40 active customers in US, UK, Scandinavia and India.

“We will continue to invest in growing our Nordic Market share, and see a clear opportunity to be the product development leader in that geography. Strong presence in that geography also helps in having a balanced customer base between Europe and US”, says Sudhakar Gorti, CEO of Proteans. (ANI)